State of Wisconsin Investment Board’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Buy |
35,046
+145
| +0.4% | +$2.17K | ﹤0.01% | 1833 |
|
|
2025
Q1 | $563K | Buy |
34,901
+3,417
| +11% | +$55.1K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $733K | Buy |
31,484
+13,169
| +72% | +$307K | ﹤0.01% | 1638 |
|
|
2024
Q3 | $539K | Buy |
18,315
+4,383
| +31% | +$129K | ﹤0.01% | 1828 |
|
|
2024
Q2 | $328K | Sell |
13,932
-700
| -5% | -$16.5K | ﹤0.01% | 1995 |
|
|
2024
Q1 | $555K | Buy |
+14,632
| New | +$555K | ﹤0.01% | 1685 |
|
|
2021
Q2 | – | Sell |
-2,412
| Closed | -$478K | – | 2155 |
|
|
2021
Q1 | $478K | Hold |
2,412
| – | – | ﹤0.01% | 1614 |
|
|
2020
Q4 | $475K | Sell |
2,412
-300
| -11% | -$59.1K | ﹤0.01% | 1547 |
|
|
2020
Q3 | $481K | Buy |
+2,712
| New | +$481K | ﹤0.01% | 1475 |
|
|
2020
Q1 | – | Sell |
-1,588
| Closed | -$303K | – | 1724 |
|
|
2019
Q4 | $303K | Buy |
1,588
+805
| +103% | +$154K | ﹤0.01% | 1531 |
|
|
2019
Q3 | $151K | Sell |
783
-101
| -11% | -$19.5K | ﹤0.01% | 1519 |
|
|
2019
Q2 | $151K | Buy |
884
+20
| +2% | +$3.42K | ﹤0.01% | 1504 |
|
|
2019
Q1 | $174K | Buy |
864
+196
| +29% | +$39.5K | ﹤0.01% | 1473 |
|
|
2018
Q4 | $125K | Buy |
+668
| New | +$125K | ﹤0.01% | 1486 |
|